Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leprosy. Recognition and treatment.

M Ramos-e-Silva1, P F Rebello

  • 1Sector of Dermatology, School of Medicine, HUCFF-UFRJ, Universidade Federal do Rio de Janeiro, State of Rio de Janeiro, Brazil. ramos.e.silva@dermato.med.br

American Journal of Clinical Dermatology
|November 14, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of keloids and hypertrophic scars. Position statement of the Brazilian expert group GREMCIQ.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Blepharochalasis: A rare presentation of cutis laxa.

Actas dermo-sifiliograficas·2019
Same author

Acne in women.

The British journal of dermatology·2015
Same author

Human leucocyte antigen frequency in a miscegenated population presenting with seborrhoeic dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2014
Same author

An index for staging facial lipoatrophy and evaluation of the efficacy of the treatment with polymethylmethacrylate in HIV/AIDS patients: a pilot study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2012
Same author

Advances in tropical diseases.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia·2011
Same journal

Circulating Tumor DNA as a Biomarker for Melanoma Prognosis and Therapy.

American journal of clinical dermatology·2026
Same journal

Defining the Potential for Disease Modification in Atopic Dermatitis.

American journal of clinical dermatology·2026
Same journal

Atopic Dermatitis: New Targets and Emerging Systemic Therapies.

American journal of clinical dermatology·2026
Same journal

Rethinking Head and Neck Atopic Dermatitis: Pathogenic Axes and Emerging Therapeutic Directions.

American journal of clinical dermatology·2026
Same journal

Correction: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.

American journal of clinical dermatology·2026
Same journal

A Systematic Review of the Clinical Impact of GLP-1 Receptor Agonists in Hidradenitis Suppurativa.

American journal of clinical dermatology·2026
See all related articles

Early diagnosis and treatment are crucial for controlling leprosy, a chronic infectious disease caused by Mycobacterium leprae. Prompt intervention prevents severe symptoms and reduces public health impact.

Area of Science:

  • Infectious Diseases
  • Dermatology
  • Neurology

Background:

  • Leprosy, caused by Mycobacterium leprae, is a chronic infectious disease affecting skin and nerves.
  • It is a stigmatizing condition prevalent in tropical and subtropical regions, necessitating early detection and treatment for control.
  • Leprosy presents with diverse clinical forms, including indeterminate, lepromatous, and tuberculoid.

Purpose of the Study:

  • To emphasize the critical role of early diagnosis and prompt therapy in managing leprosy.
  • To highlight the importance of recognizing initial disease phases to prevent severe manifestations.
  • To underscore the need for increased awareness among healthcare workers and populations in endemic areas.

Main Methods:

  • Diagnosis relies on clinical presentation, supplemented by skin bacilloscopy and histopathology.

Related Experiment Videos

  • Current treatment involves multidrug therapy (MDT) with rifampicin, clofazimine, and dapsone.
  • Therapy duration has been reduced to 12 months, with new drug combinations under evaluation.

    • Main Results:

    • Multidrug therapy effectively eliminates M. leprae and prevents resistance.
    • Reduced treatment duration to 12 months enhances patient compliance and outcomes.
    • Newer treatment regimens show promise for specific leprosy forms, such as paucibacillary leprosy.

    Conclusions:

    • Early diagnosis and intervention are paramount to preventing severe leprosy complications and reducing its public health burden.
    • Increased awareness and recognition of early leprosy signs among healthcare providers and the public are essential.
    • Continued research into novel therapeutic strategies is vital for improving leprosy control efforts worldwide.